Gene · 9476
Papers2,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ChecKAP: A Checklist for Reporting a Knowledge, Attitude, and Practice (KAP) Study. | Asian Pac J Cancer Prev | 2024 | 39068593 | PubTator, text mining | PubMed |
| Unveiling the unprecedented - Very late brain metastasis in cholangiocarcinoma: A case report and comprehensive analysis. | Medicine (Baltimore) | 2024 | 39058827 | PubTator, text mining | PubMed |
| Genetic predisposition to milder forms of COVID-19 may provide some resilience to head and neck cancers. | Front Oncol | 2024 | 39040446 | PubTator, text mining | PubMed |
The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma. | Hum Pathol | 2024 | 39029534 | PubTator, text mining | PubMed |
| Navigating the diagnostic maze: the challenge of sclerosing pneumocytoma in frozen sections. | Int J Clin Exp Pathol | 2024 | 39005235 | PubTator, text mining | PubMed |
| Primary retroperitoneal müllerian adenocarcinoma: a case report. | Front Oncol | 2024 | 38993647 | PubTator, text mining | PubMed |
| Inflammatory Giant Cell Carcinoma of the Lung: Clinicopathologic, Immunohistochemical, and Next-generation Sequencing Study of 14 Cases. | Am J Surg Pathol | 2024 | 38989701 | PubTator, text mining | PubMed |
| Multiplex Intraoperative Rapid Immunohistochemistry with Noncontact Antibody Mixing for Distinguishing the Histologic Phenotype of Lung Cancer. | Pathobiology | 2024 | 38934168 | PubTator, text mining | PubMed |
| Diagnostic value of immune-related biomarker FAM83A in differentiating malignant from benign pleural effusion in lung adenocarcinoma. | Discov Oncol | 2024 | 38914812 | PubTator, text mining | PubMed |
| An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers. | Virchows Arch | 2024 | 38904760 | PubTator, text mining | PubMed |
| Pathological findings of pulmonary papillary adenoma with EGFR mutation and literature review: two cases report. | J Cardiothorac Surg | 2024 | 38902753 | PubTator, text mining | PubMed |
| Clear cell adenocarcinoma of the cervix and its mimickers - A series of 19 cases from a tertiary care referral centre in India. | Indian J Pathol Microbiol | 2024 | 38847204 | PubTator, text mining | PubMed |
| The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks. | Cancer Cytopathol | 2024 | 38829774 | PubTator, text mining | PubMed |
| Pseudosquamous Adenocarcinoma of the Lung: Clinicopathologic and Immunohistochemical Study of 10 Cases. | Am J Surg Pathol | 2024 | 38764378 | PubTator, text mining | PubMed |
| A Curious Case of Clear Cell Morphology in a Patient with Lung Cancer: Diagnostic Challenges. | Prague Med Rep | 2024 | 38761046 | PubTator, text mining | PubMed |
| Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma. | Curr Med Chem | 2024 | 38685772 | PubTator, text mining | PubMed |
| Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion. | J Cutan Pathol | 2024 | 38468567 | PubTator, text mining | PubMed |
| Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer. | Medicine (Baltimore) | 2024 | 38394494 | PubTator, text mining | PubMed |
| Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report. | BMC Pulm Med | 2024 | 38388422 | PubTator, text mining | PubMed |
| Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer. | Cancers (Basel) | 2024 | 38339307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9476/papers?page=12